LifeStance Health Group, Inc.
LFST Nasdaq
SEC CIK 1845257
Follow LifeStance Health
Weekly email: filings, results
Revenue, last quarter
$455.9M
+25.3% vs same quarter last year
Net income
$22.4M
+1978.5% vs same quarter last year
EPS, diluted
-
Operating cash flow
$37M
+35.7% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $1.4B | $9.7M |
| FY24 | $1.3B | −$57.4M |
| FY23 | $1.1B | −$186.3M |
| FY22 | $859.5M | −$215.6M |
| FY21 | $1.4M | −$307.2M |
| FY20 | - | - |
| FY19 | $212.5M | $5.7M |
| FY18 | - | - |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | 1.7% | 0.7% |
| FY24 | −2.5% | −4.6% |
| FY23 | −17.9% | −17.6% |
| FY22 | −24.5% | −25.1% |
| FY21 | −19816.8% | −21259.3% |
| FY20 | - | - |
| FY19 | 7.2% | 2.7% |
| FY18 | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $110M |
| FY24 | $85.7M |
| FY23 | −$57.4M |
| FY22 | −$26.5M |
| FY21 | −$85.1M |
| FY20 | - |
| FY19 | $2.7M |
| FY18 | - |
- LifeStance Health
- Healthcare median
Show the numbers
| Year | LifeStance Health | Healthcare median |
|---|---|---|
| FY25 | 0.7% | −30.6% |
| FY24 | −4.6% | −47% |
| FY23 | −17.6% | −58% |
| FY22 | −25.1% | −80.4% |
| FY21 | −21259.3% | −71.9% |
| FY20 | - | −62.2% |
| FY19 | 2.7% | −46.3% |
| FY18 | - | −49.6% |